171 related articles for article (PubMed ID: 723780)
1. Evaluation of microdilution trays (sensititre) for antimicrobial susceptibility testing of Bacteroides fragilis.
Dornbusch K; Lindmark A; Nord CE
Med Microbiol Immunol; 1978 Oct; 165(3):147-51. PubMed ID: 723780
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
Sood A; Angrup A; Ray P; Bala K
Anaerobe; 2021 Oct; 71():102443. PubMed ID: 34492368
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.
Aldridge KE; Wexler HM; Sanders CV; Finegold SM
Antimicrob Agents Chemother; 1990 Jan; 34(1):179-81. PubMed ID: 2327757
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.
Cuchural GJ; Tally FP; Jacobus NV; Gorbach SL; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP
Antimicrob Agents Chemother; 1984 Aug; 26(2):145-8. PubMed ID: 6486758
[TBL] [Abstract][Full Text] [Related]
5. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
6. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility results for the Bacteroides fragilis group: comparison of the broth microdilution and agar dilution methods.
Hecht DW; Lederer L; Osmolski JR
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S342-5. PubMed ID: 7548593
[TBL] [Abstract][Full Text] [Related]
8. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
9. Survey of Bacteroides fragilis susceptibility patterns in France.
Breuil J; Burnat C; Patey O; Dublanchet A
J Antimicrob Chemother; 1989 Jul; 24(1):69-75. PubMed ID: 2777729
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
De Almeida AE; De Uzeda M
Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
Blazevic DJ
Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.
Lee K; Jang IH; Kim YJ; Chong Y
Antimicrob Agents Chemother; 1992 Jan; 36(1):195-7. PubMed ID: 1590688
[TBL] [Abstract][Full Text] [Related]
13. The changing pattern of antibiotic susceptibilities of Bacteroides fragilis in Kuwait.
Elhag KM; Mustafa AK; Pazhoor AA
J Antimicrob Chemother; 1989 Nov; 24(5):699-707. PubMed ID: 2599994
[TBL] [Abstract][Full Text] [Related]
14. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Aldridge KE
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038
[TBL] [Abstract][Full Text] [Related]
15. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.
Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge K; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP
Antimicrob Agents Chemother; 1985 Nov; 28(5):675-7. PubMed ID: 4091530
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).
Justesen US; Acar Z; Sydenham TV; Johansson Å;
Anaerobe; 2018 Dec; 54():236-239. PubMed ID: 29501419
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
18. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.
Karlowsky JA; Walkty AJ; Adam HJ; Baxter MR; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2012 Mar; 56(3):1247-52. PubMed ID: 22203594
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
Borobio MV; Domínguez MC; Pallares JA; Perea EJ
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
